Pharmaceutical company Mankind Pharma, the maker of popular condom brand Manforce, has filed its draft red herring prospectus DRHP with the Indian market regulator Securities and Exchange Board of India (SEBI).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
